Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

ASC-H ȯÀÚÀÇ p16INK4a ¸é¿ª¼¼Æ÷È­Çп°»ö °Ë»çÀÇ À¯¿ë¼º The Usefulness of p16INK4a Immunocytochemical Staining in ASC-H Patients

´ëÇѺ´¸®ÇÐȸÁö 2011³â 45±Ç 3È£ p.290 ~ 295
ÀÓ±¤ÀÏ, °­¿©ÁÖ, ±èÅÂÀº, ¹Ú°æ½Å, Á¤Àº¼±, ÃÖ¿µÁø, À̱³¿µ, °­Ã¢¼®, À̾ƿø,
¼Ò¼Ó »ó¼¼Á¤º¸
ÀÓ±¤ÀÏ ( Yim Kwang-Il ) 
°¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ º´¿øº´¸®Çб³½Ç

°­¿©ÁÖ ( Kang Yeo-Ju ) 
°¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ º´¿øº´¸®Çб³½Ç
±èÅÂÀº ( Kim Tae-Eun ) 
°¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç
¹Ú°æ½Å ( Park Gyeong-Sin ) 
°¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ º´¿øº´¸®Çб³½Ç
Á¤Àº¼± ( Jung Eun-Sun ) 
°¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ º´¿øº´¸®Çб³½Ç
ÃÖ¿µÁø ( Choi Yeong-Jin ) 
°¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ º´¿øº´¸®Çб³½Ç
À̱³¿µ ( Lee Kyo-Young ) 
°¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ º´¿øº´¸®Çб³½Ç
°­Ã¢¼® ( Kang Chang-Suk ) 
°¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ º´¿øº´¸®Çб³½Ç
À̾ƿø ( Lee Ah-Won ) 
°¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ º´¿øº´¸®Çб³½Ç

Abstract


Background : The grey zone of cervical cytology, and in particular atypical squamous cells, cannot exclude HSIL (ASC-H) causes diagnostic difficulties and increases medical expenses. We analyzed p16INK4a expression in ASC-H liquid-based cytology specimens (LBCS) to develop more effective methods for the management of ASC-H patients.

Methods : We carried out p16INK4a immunostaining with 57 LBCS of ASC-H diagnostic categories, all of which were histologically cofirmed and 43 cases of which were compared with the results of a human papillomavirus (HPV) chip test.

Results : p16INK4a immunostaining with ASC-H LBCS was positive in 20% (3/15) of cervicitis, 25.0% (3/12) of tissue-low-grade squamous intraepithelial lesion, 75.0% (18/24) of tissue-high grade squamous intraepithelial lesion (HSIL), and 100% (6/6) of invasive cancer cases. The positivity of p16INK4a in LBCS was correlated with higher grade of histologic diagnosis (r=0.578, p=0.000). The sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of p16INK4a immunostaining for the prediction of tissue-HSIL+ were 80.0%, 77.8%, 80.0%, and 77.8%, respectively. The sensitivity, specificity, PPV, and NPV of p16INK4a immunostaining plus HPV chip test for predicting tissue-HSIL+ were 71.2%, 86.4%, 84.2%, and 79.2%.

Conclusions : p16INK4a immunostaining as well as HPV chip testing with remaining LBCS with ASC-H are useful objective markers for the prediction of tissue-HSIL+.

Å°¿öµå

Cervical cancer; Cervical intraepithelial neoplasia; p16INK4a; DNA probes; HPV

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

  

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS